Emergent BioSolutions (EBS) Income from Non-Controlling Interests (2011 - 2013)

Emergent BioSolutions (EBS) recorded quarterly Income from Non-Controlling Interests of -$5000.0 in Q4 2013, up 96.09% quarter-over-quarter from -$128000.0 in Q2 2013, and up 99.55% on a YoY basis from -$2505.7 in Q4 2012.

Emergent BioSolutions (EBS) Income from Non-Controlling Interests (2011 - 2013) Analysis & Trends

Emergent BioSolutions' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$5000.0 for Q4 2013.

  • In Q4 2013, Income from Non-Controlling Interests rose 99.55% year-over-year to -$5000.0; the TTM figure through Sep 2014 stood at -$5000.0 (up 99.75% YoY), while the FY2013 annual figure was -$876000.0, up 83.72% from the prior year.
  • Income from Non-Controlling Interests was -$5000.0 for Q4 2013 at Emergent BioSolutions, up from -$128000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$5000.0 in Q4 2013 to a low of -$2.1 million in Q2 2012.
  • Historically, Income from Non-Controlling Interests has averaged -$1.1 million across 3 years, with a median of -$1.1 million in 2012.
  • The sharpest annual moves came in 2012 and 2013: Income from Non-Controlling Interests retreated 23.65% in 2012, then surged 99.55% in 2013.
  • A 3-year view of Income from Non-Controlling Interests shows it stood at -$1.8 million in 2011, then soared by 37.11% to -$1.1 million in 2012, then soared by 99.55% to -$5000.0 in 2013.
  • The last three Income from Non-Controlling Interests figures came in at -$5000.0 (Q4 2013), -$128000.0 (Q2 2013), and -$743000.0 (Q1 2013), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Emergent BioSolutions 412.09 Mn 250.59 Mn 84.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2013 -5,000.00
Jun 30, 2013 -128,000.00
Mar 31, 2013 -743,000.00
Dec 31, 2012 -1.11 Mn
Sep 30, 2012 -997,000.00
Jun 30, 2012 -2.09 Mn
Mar 31, 2012 -1.19 Mn
Dec 31, 2011 -1.76 Mn
Sep 30, 2011 -1.69 Mn
Jun 30, 2011 -1.69 Mn